Clinical trial
Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil…
NCT00151736 · Cephalon, Industry · Terminated
Key facts
| NCT number | NCT00151736 |
|---|---|
| Title | Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL) |
| Official title | A Randomized, Multi-Center, Phase II Study to Investigate the Safety and Efficacy of SDX-101 (R-etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL) |
| Lead sponsor | Cephalon, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | Chlorambucil, R-etodolac + chlorambucil |
| Enrollment | 88 |
| Start date | Sep 1, 2004 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2008 |
| First posted | Sep 9, 2005 |
| Last update posted | Jun 11, 2012 |
| Countries | France, Germany, Poland, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: